ABIGAIL KLEMME: Open Payments
NPI 1215397641 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 12 payments from 7 companies in 2025. Trend: 2023 $1,922 · 2024 $1,796 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $395 |
| Lilly USA, LLC | 3 | $238 |
| Madrigal Pharmaceuticals | 1 | $91 |
| Janssen Biotech, Inc. | 1 | $70 |
| Janssen Scientific Affairs, LLC | 1 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $43 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
Products named: SKYRIZI, OMVOH, REZDIFFRA, TREMFYA, ENTYVIO, REBYOTA.
Industry payments across WA — which companies pay providers there.
